A promising role of noble metal NPs@MOFs in chondrosarcoma management
Source abstract
Abstract
Chondrosarcoma, a challenging and malignant neoplasm originating from cartilage cells, poses significant diagnostic and therapeutic hurdles due to its resistance to conventional treatments and the complexity of its diagnosis. Noble metal nanoparticle-embedded metal-organic frameworks (NPs@MOFs) stand out as a novel approach for the diagnosis and treatment of chondrosarcoma. This review delves into the properties and applications of NPs@MOFs, focusing on their classification by noble metal type and their role in enhancing photothermal therapy (PTT), photodynamic therapy (PDT), targeted drug delivery and chondrosarcoma diagnosis. Despite promising in vitro and in vivo results, challenges such as understanding the mechanisms of action and clinical translation remain, and the therapeutic effect of PTT and PDT on deep chondrosarcoma seems unsatisfactory. Future exploration, such as combined therapy and multiple MOF therapy, could unlock the full potential of noble metal NPs@MOFs in revolutionizing chondrosarcoma management, offering insights into the prospect of these materials in chondrosarcoma management.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Machine Learning in Materials Science · Organometallic Compounds Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu 610041, China
Department of General Dentistry, West China School of Stomatology, Sichuan University, No. 14, Section 3, Renmin Nanlu, Chengdu 610041, China
Funding
National Natural Science Foundation of China · Applied Basic Research Program of Sichuan Province
References (100+)
Show source-provided references
1. Gazendam · J. Clin. Med. · 2023 · 12 · 250610.3390/jcm12072506 ↗
2. Miwa · Int. J. Mol. Sci. · 2022 · 23 · 109610.3390/ijms23031096 ↗
3. Choi · Adv. Anat. Pathol. · 2021 · 28 · 11910.1097/PAP.0000000000000293 ↗
4. Weinschenk · J. Am. Acad. Orthop. Surg. · 2021 · 29 · 553
5. Kim · Cancers · 2023 · 15 · 170310.3390/cancers15061703 ↗
6. Choi · Adv. Anat. Pathol. · 2021 · 28 · 11910.1097/PAP.0000000000000293 ↗
7. Italiano · Ann. Oncol. · 2013 · 24 · 291610.1093/annonc/mdt374 ↗
8. Amer · J. Orthop. Res. · 2020 · 38 · 31110.1002/jor.24463 ↗
9. Potter · RadioGraphics · 2024 · 44 · e24003610.1148/rg.240036 ↗
10. E. J.Geiger and N. M.Bernthal , Chondrosarcoma of the Appendicular Skeleton , in Chondrosarcoma: Biology and Clinical Management , Springer , 2021 , pp. 133–16710.1007/978-3-030-74572-1_7 ↗
11. Hua · Transl. Cancer Res. · 2020 · 9 · 425010.21037/tcr-20-357 ↗
12. Pathmanapan · Cell Rep. · 2023 · 42 · 11257810.1016/j.celrep.2023.112578 ↗
13. Sharif · Eur. J. Radiol. · 2021 · 137 · 10957910.1016/j.ejrad.2021.109579 ↗
14. Jesus-Garcia · Springerplus · 2016 · 5 · 23610.1186/s40064-016-1782-8 ↗
15. Li · Matter · 2021 · 4 · 223010.1016/j.matt.2021.03.022 ↗
16. Falcaro · Coord. Chem. Rev. · 2016 · 307 · 23710.1016/j.ccr.2015.08.002 ↗
17. Liu · Chem. Soc. Rev. · 2021 · 50 · 118810.1039/D0CS00178C ↗
18. Raza · Sustainable Mater. Technol. · 2024 · e0096310.1016/j.susmat.2024.e00963 ↗
19. Zhang · Int. J. Biol. Macromol. · 2024 · 261 · 12914610.1016/j.ijbiomac.2023.129146 ↗
20. Ge · Biomaterials · 2022 · 281 · 12132210.1016/j.biomaterials.2021.121322 ↗
21. Zhang · Adv. Mater. · 2014 · 26 · 405610.1002/adma.201400620 ↗
22. Feng · Mikrochim. Acta · 2020 · 187 · 9510.1007/s00604-019-4075-4 ↗
23. Liu · Catalysts · 2019 · 9 · 51710.3390/catal9060517 ↗
24. He · Chemosphere · 2023 · 338 · 13933910.1016/j.chemosphere.2023.139339 ↗
25. Kankala · Adv. Funct. Mater. · 2019 · 29 · 190265210.1002/adfm.201902652 ↗
26. Vincent · Cancer Cell · 2022 · 40 · 25510.1016/j.ccell.2022.01.006 ↗
27. Butler · ACS Nano · 2022 · 16 · 1962610.1021/acsnano.2c03990 ↗
28. Chao · Biomater. Res. · 2023 · 27 · 11610.1186/s40824-023-00453-z ↗
29. Grünewald · EMBO Mol. Med. · 2020 · 12 · e1113110.15252/emmm.201911131 ↗
30. Keum · Nano Convergence · 2023 · 10 · 4210.1186/s40580-023-00390-6 ↗
31. Khan · J. Nanobiotechnol. · 2023 · 21 · 13610.1186/s12951-023-01884-5 ↗
32. Ingangi · Cells · 2024 · 13 · 97710.3390/cells13110977 ↗
33. Shang · Adv. Mater. · 2017 · 29 · 160438110.1002/adma.201604381 ↗
34. Tzeng · Cell Death Dis. · 2018 · 9 · 95510.1038/s41419-018-1008-9 ↗
35. Wang · Oncogene · 2015 · 34 · 455810.1038/onc.2014.397 ↗
36. Yao · Mol. Med. Rep. · 2017 · 15 · 91510.3892/mmr.2016.6077 ↗
37. Söderström · Apmis · 2001 · 109 · 30510.1034/j.1600-0463.2001.d01-125.x ↗
38. Kohama · Cancers · 2019 · 11 · 42810.3390/cancers11030428 ↗
39. Li · Oncotarget · 2015 · 6 · 2621610.18632/oncotarget.4460 ↗
40. Mak · J. Cell. Biochem. · 2015 · 116 · 3710.1002/jcb.24940 ↗
41. Tsai · Mol. Oncol. · 2017 · 11 · 138010.1002/1878-0261.12106 ↗
42. Kim · Apoptosis · 2011 · 16 · 34710.1007/s10495-010-0567-8 ↗
43. Ramiro-Cortés · Int. J. Biochem. Cell Biol. · 2011 · 43 · 137310.1016/j.biocel.2011.06.001 ↗
44. Zhang · Sci. Rep. · 2015 · 5 · 1257910.1038/srep12579 ↗
45. Geng · Chem. Eng. J. · 2022 · 441 · 13596410.1016/j.cej.2022.135964 ↗
46. Khan · Adv. Colloid Interface Sci. · 2023 · 321 · 10300710.1016/j.cis.2023.103007 ↗
47. Li · Adv. Funct. Mater. · 2023 · 33 · 230325410.1002/adfm.202303254 ↗
48. Tan · Chem. Eng. J. · 2020 · 390 · 12446
49. Ji · Oncol. Res. · 2014 · 22 · 18510.3727/096504015X14343704124340 ↗
50. Li · Nano Res. · 2018 · 11 · 329410.1007/s12274-017-1874-y ↗
51. Liu · Oncotarget · 2014 · 5 · 1071810.18632/oncotarget.2532 ↗
52. Maeda · Adv. Drug Delivery Rev. · 2013 · 65 · 7110.1016/j.addr.2012.10.002 ↗
53. Miot-Noirault · Nanomedicine · 2014 · 10 · 188710.1016/j.nano.2014.06.011 ↗
54. Soyekwo · J. Membr. Sci. · 2023 · 685 · 12192110.1016/j.memsci.2023.121921 ↗
55. Raza · Int. J. Biol. Macromol. · 2024 · 254 · 12715310.1016/j.ijbiomac.2023.127153 ↗
56. Yin · J. Cancer Res. Ther. · 2024 · 20 · 52210.4103/jcrt.jcrt_2269_23 ↗
57. Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group · J. Bone Jt. Surg., Am. Vol. · 2007 · 89 · 211310.2106/00004623-200710000-00003 ↗
58. Song · Spine · 2020 · 45 · 111010.1097/BRS.0000000000003494 ↗
59. Abdulfatah · Hum. Pathol. · 2023 · 136 · 6310.1016/j.humpath.2023.03.011 ↗
60. Aran · Crit. Rev. Oncol. Hematol. · 2021 · 162 · 10334010.1016/j.critrevonc.2021.103340 ↗
61. Compton · Am. J. Surg. Pathol. · 2020 · 44 · 11110.1097/PAS.0000000000001397 ↗
62. El Beaino · Curr. Oncol. Rep. · 2023 · 25 · 111710.1007/s11912-023-01441-1 ↗
63. Hompland · Eur. J. Cancer · 2021 · 151 · 15010.1016/j.ejca.2021.04.017 ↗
64. Ghigna · Eur. Respir. Rev. · 2021 · 30 · 110.1183/16000617.0309-2020 ↗
65. Serban · EFORT Open Rev. · 2023 · 8 · 60610.1530/EOR-23-0095 ↗
66. Shi · Cancer Cell · 2022 · 40 · 120710.1016/j.ccell.2022.08.012 ↗
67. Hu · ACS Nano · 2017 · 11 · 555810.1021/acsnano.7b00905 ↗
68. Kang · Biochim. Biophys. Acta, Rev. Cancer · 2023 · 1878 · 18898810.1016/j.bbcan.2023.188988 ↗
69. Pascale · Cancers · 2020 · 12 · 281910.3390/cancers12102819 ↗
70. Vaupel · J. Physiol. · 2021 · 599 · 174510.1113/JP278810 ↗
71. Wang · Trends Cell Biol. · 2023 · 33 · 101410.1016/j.tcb.2023.03.013 ↗
72. Zhong · J. Hematol. Oncol. · 2022 · 15 · 16010.1186/s13045-022-01358-5 ↗
73. Beird · Nat. Rev. Disease Primers · 2022 · 8 · 7710.1038/s41572-022-00409-y ↗
74. Gao · Chin. Chem. Lett. · 2021 · 32 · 219210.1016/j.cclet.2020.12.036 ↗
75. Lin · Signal Transduction Targeted Ther. · 2021 · 6 · 40410.1038/s41392-021-00817-8 ↗
76. Liu · Chin. Chem. Lett. · 2022 · 33 · 185510.1016/j.cclet.2021.08.117 ↗
77. Tarighati · Clin. Exp. Med. · 2023 · 23 · 1
78. Hall · Ann. Coloproctol. · 2019 · 35 · 29410.3393/ac.2019.11.13 ↗
79. Hanif · World J. Gastroenterol. · 2022 · 28 · 21610.3748/wjg.v28.i2.216 ↗
80. Joshi · Sci. Rep. · 2022 · 12 · 1531510.1038/s41598-022-19593-8 ↗
81. Karele · Biochim. Biophys. Acta, Rev. Cancer · 2022 · 1877 · 18879610.1016/j.bbcan.2022.188796 ↗
82. Kremenevski · Neuroendocrinology · 2020 · 110 · 83610.1159/000509386 ↗
83. Tzortzidis · Neurosurgery · 2006 · 58 · 109010.1227/01.NEU.0000215892.65663.54 ↗
84. Ulici · Arch. Pathol. Lab. Med. · 2022 · 146 · 38610.5858/arpa.2020-0258-RA ↗
85. Kubota · Noshuyo Byori · 1994 · 11 · 23
86. Ahandoust · Osteoarthritis Cartilage · 2023 · 31 · 69410.1016/j.joca.2023.02.039 ↗
87. Varshney · Am. Soc. Clin. Oncol. · 2022 · 503610.1200/JCO.2022.40.16_suppl.5036 ↗
88. Kamishov · Am. Soc. Clin. Oncol. · 2022 · e1256310.1200/JCO.2022.40.16_suppl.e12563 ↗
89. Rizzo · Clin. Orthop. Relat. Res. · 2001 · 22410.1097/00003086-200110000-00025 ↗
90. Hua · Transl. Cancer Res. · 2020 · 9 · 425010.21037/tcr-20-357 ↗
91. Deng · Nano Lett. · 2019 · 19 · 677210.1021/acs.nanolett.9b01716 ↗
92. Zhang · Adv. Healthcare Mater. · 2018 · 7 · e180114410.1002/adhm.201801144 ↗
93. Gorelik · Cancer Res. · 2008 · 68 · 903310.1158/0008-5472.CAN-08-1723 ↗
94. Coluccia · Eur. J. Med. Chem. · 2022 · 244 · 11480110.1016/j.ejmech.2022.114801 ↗
95. Sun · Signal Transduction Targeted Ther. · 2023 · 8 · 41810.1038/s41392-023-01642-x ↗
96. Wallander · J. Intern. Med. · 2023 · 294 · 69010.1111/joim.13717 ↗
97. Zhou · Biosens. Bioelectron. · 2017 · 98 · 8310.1016/j.bios.2017.06.039 ↗
98. Li · Signal Transduction Targeted Ther. · 2021 · 6 · 38310.1038/s41392-021-00779-x ↗
99. Li · Biosens. Bioelectron. · 2020 · 168 · 11255410.1016/j.bios.2020.112554 ↗
100. Tan · TrAC, Trends Anal. Chem. · 2023 · 167 · 11725310.1016/j.trac.2023.117253 ↗